Clinical Trial Update: Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer [Phase 1]

View source ↗

Summary

Phase 1 dose-finding trial of everolimus for stage IV or recurrent cervical cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Accelerated Community Oncology Research Network | Conditions: Cervical Cancer | Phase 1 | Status: WITHDRAWN